Matteo Brizio

535 total citations
18 papers, 155 citations indexed

About

Matteo Brizio is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Matteo Brizio has authored 18 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Biotechnology. Recurrent topics in Matteo Brizio's work include Cutaneous Melanoma Detection and Management (10 papers), Microbial Inactivation Methods (6 papers) and Melanoma and MAPK Pathways (5 papers). Matteo Brizio is often cited by papers focused on Cutaneous Melanoma Detection and Management (10 papers), Microbial Inactivation Methods (6 papers) and Melanoma and MAPK Pathways (5 papers). Matteo Brizio collaborates with scholars based in Italy, United Kingdom and Germany. Matteo Brizio's co-authors include Pietro Quaglino, Simone Ribero, Maria Teresa Fierro, Paolo Fava, P. Curatolo, L Campana, Francesca de Terlizzi, Chiara Astrua, Joy Odili and Christian Kunte and has published in prestigious journals such as Cancers, Journal of Clinical Medicine and Journal of the European Academy of Dermatology and Venereology.

In The Last Decade

Matteo Brizio

18 papers receiving 154 citations

Peers

Matteo Brizio

BIOTE

ONCOL

IMMUN

DERMA

Pavithra Rajagopalan United States

Xiu Teng China

Joleen J.H. Traets Netherlands

Birgit S. Geurts Netherlands

Laura Bigi Italy

Tejeshwar Jain United States

Geniver El Tekle United States

Carlo Cabula Italy

Ching‐Leou Teng United States

Antoni Bennássar Spain

Pavithra Rajagopalan United States

Matteo Brizio

10 ×0.2

BIOTE

63 ×1.1

ONCOL

33 ×0.7

IMMUN

143 ×4.0

33 ×1.2

DERMA

Citations per year, relative to Matteo Brizio Matteo Brizio (= 1×) peers Pavithra Rajagopalan

Countries citing papers authored by Matteo Brizio

Since Specialization

Citations

This map shows the geographic impact of Matteo Brizio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Brizio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Brizio more than expected).

Fields of papers citing papers by Matteo Brizio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Brizio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Brizio. The network helps show where Matteo Brizio may publish in the future.

Co-authorship network of co-authors of Matteo Brizio

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Brizio. A scholar is included among the top collaborators of Matteo Brizio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Brizio. Matteo Brizio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Roccuzzo, Gabriele, Chiara Astrua, Matteo Brizio, et al.. (2024). Treatment Patterns and Outcomes of Stage III Melanoma Patients with Positive Sentinel Lymph Node Biopsy: A Real-Life Experience. Journal of Clinical Medicine. 13(17). 5238–5238. 1 indexed citations

Roccuzzo, Gabriele, Paolo Fava, Chiara Astrua, et al.. (2024). Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma. Cancers. 16(17). 3095–3095. 3 indexed citations

Rubatto, Marco, Paolo Fava, Matteo Brizio, et al.. (2022). Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study. Dermatologic Therapy. 35(6). e15492–e15492. 5 indexed citations

Campana, L, Pietro Quaglino, Francesca de Terlizzi, et al.. (2022). Health‐related quality of life trajectories in melanoma patients after electrochemotherapy: real‐world insights from the InspECT register. Journal of the European Academy of Dermatology and Venereology. 36(12). 2352–2363. 8 indexed citations

Quaglino, Pietro, Paolo Fava, Matteo Brizio, et al.. (2021). Anti-BRAF/Anti-MEK Targeted Therapies for Metastatic Melanoma Patients During the COVID-19 Outbreak: Experience from an Italian Skin Cancer Unit. Future Oncology. 17(7). 759–761. 4 indexed citations

Farricha, Víctor, Pietro Quaglino, Matteo Brizio, et al.. (2020). Safety and efficacy of electrochemotherapy in a series of patients with nonmetastasized primary or recurrent anorectal malignant melanoma. Melanoma Research. 31(1). 76–80. 3 indexed citations

Quaglino, Pietro, Paolo Fava, Matteo Brizio, et al.. (2020). Metastatic melanoma treatment with checkpoint inhibitors in the COVID‐19 era: experience from an Italian Skin Cancer Unit. Journal of the European Academy of Dermatology and Venereology. 34(7). 1395–1396. 16 indexed citations

Campana, L, Erika Kis, Antonio Orlando, et al.. (2019). Electrochemotherapy for advanced cutaneous angiosarcoma: A European register-based cohort study from the International Network for Sharing Practices of electrochemotherapy (InspECT). International Journal of Surgery. 72. 34–42. 22 indexed citations

Clover, A. James P., Giulia Bertino, P. Curatolo, et al.. (2019). Electrochemotherapy in the treatment of cutaneous malignancy; outcomes and subgroup analysis from the cumulative results from the pan- European InspECT Database for 1478 lesions in 691 patients (2008-2018). European Journal of Surgical Oncology. 45(2). e19–e19. 5 indexed citations

10.

Campana, L, Pietro Quaglino, Falk G. Bechara, et al.. (2019). Electrochemotherapy in melanoma: a European e-Delphi survey to define a consensus on indications, treatment modalities and quality indicators. European Journal of Surgical Oncology. 45(2). e18–e18. 1 indexed citations

11.

Rotunno, Roberta, L Campana, Pietro Quaglino, et al.. (2017). Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry. Journal of the European Academy of Dermatology and Venereology. 32(7). 1147–1154. 37 indexed citations

12.

Fava, Paolo, Chiara Astrua, Martina Sanlorenzo, et al.. (2017). Treatment of metastatic melanoma: a multidisciplinary approach. Italian Journal of Dermatology and Venereology. 152(3). 241–261. 8 indexed citations

13.

Astrua, Chiara, Paolo Fava, Matteo Brizio, & Paola Savoia. (2017). A study of melanoma in Eastern European migrants in Italy. European Journal of Dermatology. 27(2). 139–143. 5 indexed citations

14.

Ribero, Simone, Matteo Brizio, Franco Picciotto, et al.. (2016). Metastatic sebaceous cell carcinoma, review of the literature and use of electrochemotherapy as possible new treatment modality. Radiology and Oncology. 50(3). 308–312. 9 indexed citations

15.

Fava, Paolo, Elena Marra, Chiara Astrua, et al.. (2016). Dermatological approach to vemurafenib skin toxicity: a single centre experience.. PubMed. 151(1). 25–31. 2 indexed citations

16.

Fava, Paolo, Massimiliano Bergallo, Chiara Astrua, et al.. (2015). Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas. Dermatology. 232(1). 38–43. 15 indexed citations

17.

Fava, Paolo, Chiara Astrua, Giovanni Cavaliere, et al.. (2014). Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature. Journal of the European Academy of Dermatology and Venereology. 29(9). 1843–1845. 4 indexed citations

18.

Fierro, Maria Teresa, Annamaria Cuffini, Mauro Novelli, et al.. (2011). Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients. European Journal of Dermatology. 21(6). 921–929. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact